Scientists have shown ageing process can be safely and effectively reversed in mice
New research by the Salk Institute has shown cellular rejuvenation therapy safely reverses signs of ageing in mice.
List view / Grid view
New research by the Salk Institute has shown cellular rejuvenation therapy safely reverses signs of ageing in mice.
Scientists have gained deeper knowledge about the mislocalisation of a protein, providing a possible therapeutic target that could have implications in treating dementia.
An iPSC technology leader taps industry veteran to drive growth in cell therapy and drug discovery markets.
Long-awaited findings about cell differentiation will be relevant in understanding normal development and may also be useful in cancer research.
Researchers have successfully generated organoids in suspension, offering the possibility of larger-scale experiments to study human development and disease.
Researchers have innovated the petri dish to be able to grow and age live brain cells from patients with neurological disorders.
Researchers have identified potential age-related macular degeneration drugs using a novel stem-cell based research tool.
New research has shown that one-time infusion of stem cells from bone marrow improves the survival of mice with sepsis.
Researchers have made a respiratory model of COVID-19, made from patient-derived stem cells, to understand how the virus affects respiration and which could be used to test possible drugs.
The first patient-derived stem cell model to research eye conditions related to oculocutaneous albinism (OCA) has been created.
Scientists in Japan have developed a credible heart cell model for arrhythmogenic cardiomyopathy and observed a positive response in the condition using PKP2 gene therapy.
Benefits and key considerations of using human iPSC-derived disease models in drug discovery.
Scientists have developed a multi-organoid system from stem cells that can replicate the liver-islet axis in type 2 diabetes.
Urea cycle disorders affect the liver’s ability to excrete urea from the body. To test potential therapeutics requires an accurate model – a hurdle that has now been successfully navigated thanks to a team of researchers in Switzerland.
Whitepaper discusses strategies to optimize various factors that cause off-target events with Invitrogen™ TrueCut™ HiFi Cas9 Protein.